A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Public ClinicalTrials.gov record NCT00096993. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy of Pertuzumab (rhuMAb 2C4) in Combination With Gemcitabine and the Effect of Tumor-Based HER2 Activation in Subjects With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase II, randomized, placebo-controlled, double-blind, multicenter clinical trial of pertuzumab in combination with gemcitabine relative to placebo in combination with gemcitabine in subjects with advanced ovarian, primary peritoneal, or fallopian tube cancer that is resistant to platinum-based chemotherapy.
Study identification
- NCT ID
- NCT00096993
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 131 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2005 (Type not available)
- Primary completion
- Sep 2007 (Actual)
- Completion
- Sep 2007 (Actual)
- Last update posted
- Jun 10, 2015
2005 – 2007
United States locations
- U.S. sites
- 41
- U.S. states
- 21
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ. of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| Comprehensive Cancer Institute | Huntsville | Alabama | 35801 | — |
| Northwest Alabama Cancer Center | Muscle Shoals | Alabama | 35661 | — |
| Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| Alta Bates Comp. Cancer Ctr | Berkeley | California | 94704 | — |
| California Cancer Crae, Inc | Greenbrae | California | 94904 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| University of California, Los Angeles | Los Angeles | California | 90095 | — |
| Ventura County Hematology Oncology Specialists | Oxnard | California | 93030 | — |
| Sutter Cancer Center | Sacramento | California | 95816 | — |
| Southern California Permanente Medical Group (Kaiser) | San Diego | California | 92120 | — |
| Sharp Healthcare | San Diego | California | 92123 | — |
| Norwalk Medical Group | Norwalk | Connecticut | 06856 | — |
| Hematology Oncology, P.C. | Stamford | Connecticut | 06902 | — |
| Integrated Community Oncology Network | Jacksonville | Florida | 32256 | — |
| Florida Hospital | Orlando | Florida | 32804 | — |
| Memorial Health Univ. Med. Ctr. | Savannah | Georgia | 31404 | — |
| St. Luke's Mountain States Tumor Institute | Boise | Idaho | 83712 | — |
| North Idaho Cancer Center | Coeur d'Alene | Idaho | 83814 | — |
| University Of Chicago | Chicago | Illinois | 60637 | — |
| Carle Clinic Association | Urbana | Illinois | 61801 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| St. Vincent Hospital | Indianapolis | Indiana | 46260 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| University of Kentucky | Lexington | Kentucky | 40536 | — |
| Greater Baltimore Medical Center | Baltimore | Maryland | 21204 | — |
| Franklin Square Hospital Center | Baltimore | Maryland | 21237 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Wayne State Univ. Barbara Ann Karmanos Cancer Inst. | Detroit | Michigan | 48201 | — |
| Center for Cancer and Hematologic Disease | Cherry Hill | New Jersey | 08003 | — |
| Cooper Health System | Voorhees Township | New Jersey | 08043 | — |
| Carolinas Medical Center | Charlotte | North Carolina | 28203 | — |
| Ohio State University College of Medicaine | Columbus | Ohio | 43210 | — |
| Pelvic Surgery Assoc. | Columbus | Ohio | 43222 | — |
| Oklahoma Univ. Medical Center | Oklahoma City | Oklahoma | 73104 | — |
| Corvallis Clinic | Corvallis | Oregon | 97330 | — |
| Kaiser Permanente Northwest Division | Portland | Oregon | 97227 | — |
| Womens and Infants Hospital | Providence | Rhode Island | 02905 | — |
| Northern Virginia Pelvic Surgery Assoc. | Annandale | Virginia | 22003 | — |
| Carilion Gyn/Onc | Roanoke | Virginia | 24014 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00096993, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 10, 2015 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00096993 live on ClinicalTrials.gov.